cysteine protease (Merck Frosst)

N/A

Report date: 2025/03/19 20:00:56

NME

Base Information

Drug Namecysteine protease (Merck Frosst)

Drug Alias NameHuntingtons disease therapeutics (Merck Frosst)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApoptosis inhibitors

TargetsUpdating

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Canada Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMerck Canada Inc

Active IndicationsN/A

Inactive IndicationsHuntington Disease

ATC CodeN/A